On-body Drug Delivery Devices - Intellectual Property Landscape: Focus on Popular / Relevant Prior Art Search Expressions, Patent Valuation, Pockets of Innovation / White Spaces, and Key Applicant Profiles

On-body Drug Delivery Devices - Intellectual Property Landscape: Focus on Popular / Relevant Prior Art Search Expressions, Patent Valuation, Pockets of Innovation / White Spaces, and Key Applicant Profiles

Chronic diseases, such as diabetes, arthritis, hypertension and cancer, are considered among the leading causes of death, worldwide. In fact, a recent study revealed that the global failure to control the steady rise in preventable risk factors associated with the aforementioned conditions, rendered populations vulnerable to COVID-19. Although there are several national and global-level initiatives focused on educating the masses on prevention and promote healthy living, individuals living with a chronic medical condition are required to medicate on a frequent basis – which is often multiple times in a single day. Lack of adherence to prescribed medication regimens (due to various reasons) and high cost of treatment (a significant share of which stems from non-compliance to treatment), are the major contributing factors to the associated burden on patients and the healthcare system. However, modern therapy administration technology, such as wearable and implantable drug delivery solutions, allows patients to effectively deal with several of the areas of concern related to therapy adherence and treatment costs.

With provisions to adhere to, or be implanted in the body, this advanced category of drug delivery solutions are known to (1) enable patients to self-medicate (thereby, saving on routine hospital visit fees), (2) effectively reduce the number of needle-pricks in case of patients who are required to medicate multiple times in a day, (3) administer large volumes (more than 2 mL) of therapeutic formulations over an extended period of time, and (4) improve compliance to therapeutic regimens (some devices include provisions for monitoring / tracking dosing). The advantages of on-body drug delivery devices are numerous; consequently, the demand for such devices is also high and growing, which is projected to grow to a USD 600 million market by 2030. Within such a lucrative and rapidly evolving market it is imperative for innovators and other stakeholders (including interested investors) to regularly track the growing intellectual capital. In this context, we have analyzed the intellectual property landscape related to on-body (wearable and implantable) drug delivery solutions, and developed independent opinions on both historical and recent trends, and other key attributes of the innovation in this upcoming field of medical technology.

SCOPE OF THE REPORT

The “On-body Drug Delivery Devices - Intellectual Property Landscape” report features an extensive study of the historical and current collection of granted patents, patent applications and affiliated documents associated with modern wearable / implantable therapy administration solutions. The information in this report has been presented across two deliverables, namely an Excel sheet, featuring an interactive dashboard, and a PowerPoint presentation, summarizing the ongoing activity in this domain, and key insights drawn from the available data. The report features the following details:

Overall Intellectual Property Landscape

An in-depth analysis of the various patents and affiliated IP documents that have been published related to technologies and methods associated with wearable / implantable drug delivery devices, featuring key insights from historical and recent trends

Popular / Relevant Prior Art Search Expressions

An examination of IP literature, identifying key words and phrases that are used to describe innovations in portable, large volume drug dispensing solutions, including information on historical usage in IP filings, key affiliated terms (which can be used to further identify similar innovations), and other related trends

Patent Valuation Analysis

A competitive benchmarking and valuation analysis, taking into account important IP associated parameters, such as type of IP document, year of application, time to expiry, number of citations and jurisdiction (taking into consideration regional GDP), where the IP application was filed

Pockets of Innovation and White Spaces

An analysis of the CPC symbols and affiliated families, to identify historical and existing pockets of innovation, featuring an insightful discussion on the prevalent white spaces in this area of research

Company Profiles

Detailed profiles of the key players that have the maximum number of IP publication in the period between 2001-2021, including overview of the company, financial information (if available), and its proprietary IP related trends

RESEARCH METHODOLOGY

The data presented in this report has been gathered via secondary research and analyzed via proprietary methods / tools to develop a detailed perspective on the current status of the developer landscape across different global regions. Where possible, the available data has been checked for accuracy from multiple sources of information.

The secondary sources of information include

Company websites

Annual reports

Investor presentations

Industry databases

Press releases

Government policy documents

Clinical trial registries / databases (such as www.clinicaltrials.gov)

Industry analysts’ views

The insights presented are solely based on our knowledge, research and understanding of the relevant market, as gathered from various secondary sources of information.

DELIVERABLE OUTLINES

Excel Deliverable

1. The first section of the spreadsheet features details on how the input data for this project was collated, including the search strings used to query the lens.org patent database and noise removal criteria.

2. The second section of the deliverable is a summary MS Excel dashboard, offering a detailed graphical perspective of the intellectual property landscape of on-body drug delivery solutions, highlighting trends key patent / patent application publication trends, CPC symbol usage over time and intellectual capital-related publication trends of key applicants that are engaged in this industry

3. The third section of the spreadsheet is an elaborate table, which features a long list of all the intellectual capital (namely granted patents, patent applications, limited patents, amended patents, abstracts, statutory invention registration and search reports) related publications, for which the relevant details are available in the public domain.

4. The next section of the deliverable includes an analysis of the key CPC symbols, highlighting usage trends (since 2001) related to the top CPC symbol and CPC families, used by innovators in this field of medical technology to describe their respective products / technologies / methods of use.

5. The final section of the deliverable includes an analysis of the key applicants that have published the various types of intellectual property documents that have been considered in this report. It also features another table, which includes information on the top 25 applicants, based on the number of intellectual capital related publications, in the period 2001-2021

PowerPoint Deliverable

1. The first part of this deliverable features an executive summary of the key insights generated from analyzing the intellectual property landscape associated with on-body drug delivery devices.

2. The next part provides important details related to on-body drug delivery devices, including key product related definitions, advantages of the technology and the methodology used (in this project) to query the public database, lens.org, for information on the published intellectual capital related to this innovation.

3. The third section of the deliverable includes charts and figures describing the overall intellectual property landscape of on-body drug delivery devices and affiliated technologies / methods of use.

4. The next section of the deliverable includes charts and figures describing the intellectual property landscape of on-body drug delivery devices and affiliated technologies / methods of use, since 2001.

5. The subsequent section features insights from a detailed analysis of the titles of patent / patent applications related to wearable and implantable drug delivery solutions. It includes multiple word clouds, which help identify the most important keywords that can be used for prior art research specific to this field.

6. The sixth section provides our independent views on the relative valuation of the intellectual property related to on-body drug delivery devices, taking into account important associated parameters, such as type of document, year of application, time to expiry, number of citations and jurisdiction (taking into consideration regional GDP), where the IP application was filed.

7. The next section features an analysis of the CPC symbols and affiliated families, to identify historical and existing pockets of innovation, and also includes an insightful discussion on the prevalent white spaces in this area of research.

8. Finally, it includes profiles of the companies having the maximum number of intellectual capital related publication in the period between 2001-2021, including overview of the company, financial information (if available), and its proprietary intellectual property publication related trends.

LIST OF COMPANIES / LIST OF COMPANIES AND ORGANIZATIONS

The following companies and organizations have been mentioned in the report.

1. 3D Medicines

2. 3M

3. 89Bio

4. AB2 Bio

5. Abbott

6. AbbVie

7. AbGenomics

8. Ablynx

9. Acceleron Pharma

10. Accenture

11. Acer Therapeutics

12. ADC Therapeutics

13. Adisave

14. Adrenomed

15. Aduro BioTech

16. Advaxis

17. Aeglea BioTherapeutics

18. Aetna

19. Affibody

20. Affimed

21. Affinivax

22. Agenus

23. AgonOx

24. Akcea Therapeutics

25. Akero Therapeutics

26. Akeso Tiancheng

27. Akesobio Australia

28. Alder BioPharmaceuticals

29. Alector

30. Alexion Pharmaceuticals

31. Alkahest

32. Alkermes

33. Allakos

34. Allergan

35. Allozyne

36. Alnylam Pharmaceuticals

37. Alopexx Oncology

38. AlphaCore Pharma

39. Alphamab

40. Altor BioScience

41. Ambrx

42. Amgen

43. Amicus Therapeutics

44. Amphivena Therapeutics

45. Amplyx Pharmaceuticals

46. AnaptysBio

47. Andes Biotechnologies

48. Angiochem

49. Antares Pharma

50. Antaros Medical

51. Apellis Pharmaceuticals

52. Aptevo Therapeutics

53. Araclon Biotech

54. argenx

55. Argos Therapeutics

56. ArmaGen

57. ARMO BioSciences

58. Aronora

59. Arrowhead Pharmaceuticals

60. Asante Solutions

61. Ascendis Pharma

62. Ascensia Diabetes Care

63. ASIT Biotech

64. Asklepion Pharmaceuticals

65. ASLAN Pharmaceuticals

66. Astellas Pharma

67. Astorg

68. AstraZeneca

69. Atridia

70. Australasian Medical & Scientific

71. Avillion

72. Axon Neuroscience

73. Baril

74. Basilea Pharmaceutica

75. Bastian Solutions

76. Battelle

77. Bavarian Nordic

78. Baxalta

79. Baxter International

80. Bayer

81. Bayhill Therapeutics

82. Becton Dickinson

83. BeiGene

84. Beijing Dongfang Biotech

85. Beijing Northland Biotech

86. Bern University

87. Bespak

88. Beta Bionics

89. Bigfoot Biomedical

90. BioArctic

91. BIOCAD

92. Biocon

93. Biogen

94. BioIntegrator

95. Bioject Medical Technologies

96. BioMarin Pharmaceutical

97. Biomay

98. BioMimetix

99. Bioniz Therapeutics

100. BioNTech

101. Bio-Path Holdings

102. Biotest Pharmaceuticals

103. Bio-Thera Solutions

104. BJ Bioscience

105. Boehringer Ingelheim

106. Boston Pharmaceuticals

107. Buehler Motor

108. Calando Pharmaceuticals

109. Calibr

110. Calibra Medical

111. Cam Med

112. CANbridge Life Sciences

113. Cancer Advances

114. Cara Therapeutics

115. Cardiome Pharma

116. Care Innovations

117. CareFusion

118. Catalyst Biosciences

119. Celgene

120. Celldex Therapeutics

121. CEL-SCI

122. CeQur

123. Changchun BCHT Biotechnology

124. Chimerix

125. CHO Pharma

126. Chugai Pharmaceutical

127. CiVi Biopharma

128. Cleveland BioLabs

129. Conjupro Biotherapeutics

130. Consort Medical

131. ContraFect

132. ConvaTec

133. Cordant Group

134. Corvidia Therapeutics

135. Cour Pharmaceutical Development

136. CRISI Medical Systems

137. CSL Behring

138. CStone Pharmaceuticals

139. CuraVac

140. CureTech

141. CytoDyn

142. Daikyo Seiko

143. Datwyler

144. Debiotech

145. DEKA

146. Dekkun

147. Delta-Fly Pharma

148. Dendreon

149. Dermira

150. Desentum

151. DexCom

152. Diabeloop

153. DiaMedica Therapeutics

154. Dicerna Pharmaceuticals

155. DreaMed Diabetes

156. Duke Clinical Research Institute

157. Duke University

158. E3D Elcam Drug Delivery Devices

159. ECHAlliance

160. Eddingpharm

161. Eiger BioPharmaceuticals

162. Eisai

163. Eitan Group

164. Elcam group

165. Eli Lilly

166. Elusys Therapeutics

167. EMD Serono

168. Emergent BioSolutions

169. Enable Injections

170. Endocyte

171. EnGeneIC

172. EOC Pharma

173. EOFlow

174. EpicentRx

175. Equillium

176. Eris Lifesciences

177. Etubics

178. EVER Pharma

179. Ever Supreme Bio Technology

180. Evidation Health

181. F2G

182. Fabrico

183. Ferring Pharmaceuticals

184. FibroGen

185. Fitbit

186. Five Prime Therapeutics

187. Flex Pharma

188. Flextronics

189. Flowonix Medical

190. Galaxy Biotech

191. Galena Biopharma

192. GENCO

193. GeneCure Biotechnologies

194. Genentech (Roche)

195. GENERON

196. GeneScience Pharmaceuticals

197. Genexine

198. Genocea Biosciences

199. Genor Biopharma

200. Genzyme

201. Georgia Institute of Technology

202. Gerresheimer

203. Gilead Sciences

204. GlaxoSmithKline

205. Glenmark Pharmaceuticals

206. Gliknik

207. GlobeImmune

208. Glooko

209. GLyPharma Therapeutic

210. Guangzhou Cellprotek Pharmaceutical

211. HAL Allergy

212. Halozyme Therapeutics

213. HanAll Biopharma

214. Hanmi Pharmaceutical

215. Harbour BioMed

216. Harvard Pilgrim Health Care

217. Haselmeier

218. HealthPrize Technologies

219. Helsinn Healthcare

220. Hepatera

221. Hoffmann-La Roche

222. Huabo Biopharm

223. IBM Watson

224. IDF Europe (International Diabetes Federation)

225. ILTOO Pharma

226. ImClone Systems

227. Immatics Biotechnologies

228. Immune Response BioPharma

229. ImmunGene

230. Immunocore

231. ImmunoFrontier

232. ImmunoGen

233. Immunomedics

234. Immunotope

235. Immunovaccine

236. ImmuPharma

237. Immutep

238. Implicit Bioscience

239. Incuron

240. Incyte

241. INmune Bio

242. Innate Pharma

243. Innovent Biologics

244. Inovio Pharmaceuticals

245. Insulet

246. iNtRON Biotechnology

247. IO Biotech

248. Ionis Pharmaceuticals

249. Ipsen

250. IQVIA Biotech

251. ISA Pharmaceuticals

252. iSense CGM

253. ISU ABXIS

254. Izana Bioscience

255. Janssen

256. Jerini

257. JHL Biotech

258. Jiangsu Hengrui Medicine

259. Jiangsu T-Mab Biopharma

260. Johnson & Johnson

261. Jounce Therapeutics

262. Juvenile Diabetes Research Foundation

263. KaloBios Pharmaceuticals

264. Kangstem Biotech

265. Kinevant Sciences

266. Kissei Pharmaceutical

267. Klue

268. Kura Oncology

269. Kyowa Hakko Kirin

270. Kyowa Hakko Kirin

271. Labrys Biologics

272. LEO Pharma

273. Levicept

274. LIB Therapeutics

275. Luye Pharma

276. MabVax Therapeutics

277. MacroGenics

278. Maruho

279. Massachusetts Institute of Technology

280. MedImmune

281. Medimop Medical Projects

282. Medipacs

283. Medtronic

284. Medtrum Technologies

285. Menarini Diagnostics

286. Merck

287. Merck Sharp & Dohme

288. Mercy Technology Services

289. Mereo BioPharma

290. Merrimack Pharmaceuticals

291. Mersana Therapeutics

292. Merus

293. Merz Pharma

294. MicroVAX

295. Millennium Pharmaceuticals

296. MiNA Therapeutics

297. miRagen Therapeutics

298. Mitsubishi Tanabe Pharma

299. Mode Automated Glucose Control

300. Moderna Therapeutics

301. Molecular Partners

302. Molecular Templates

303. MolMed

304. Montagu Private Equity

305. Morphogenesis

306. MorphoSys

307. Morphotek

308. Movi

309. MTD Micro Molding

310. MYR Pharmaceuticals

311. mySugr (Acquired by Roche)

312. NanoPass Technologies

313. NantBioScience

314. National Cancer Institute

315. Naurex

316. Navidea Biopharmaceuticals

317. Nemera

318. Neogenix Oncology

319. Neon Therapeutics

320. Neumedicines

321. NeuroDerm

322. New Zealand Medical & Scientific

323. NGM Biopharmaceuticals

324. Noble

325. Nordic Bioscience

326. Nordic Infucare

327. Northern Biologics

328. Novartis Pharmaceuticals

329. Novimmune

330. NOVO Engineering

331. Novo Nordisk

332. Nutrino Health (Acquired by Medtronic)

333. OBI Pharma

334. Octapharma

335. OliX Pharmaceuticals

336. Omeros

337. Oncolix

338. Oncology Venture

339. OncoMed Pharmaceuticals

340. OncoPep

341. Oncopeptides

342. Oncternal Therapeutics

343. Oncurious

344. Opexa Therapeutics

345. OPKO Health

346. Optimer Pharmaceuticals

347. Orphan Technologies

348. OSE Immunotherapeutics

349. Otsuka Pharmaceutical

350. Paion UK

351. Panacea Biotec

352. PercuSense

353. Pfizer

354. PharmaJet

355. PharmaMar

356. PharmaSens

357. PhaseBio Pharmaceuticals

358. Phillips-Medisize

359. Philogen

360. Phosplatin Therapeutics

361. Pierre Fabre

362. Pique Therapeutics

363. Plus Therapeutics (formerly Cytori Therapeutics)

364. Polaris Group

365. Polyphor

366. Prescient Therapeutics

367. Prestige BioPharma

368. Promedior

369. Prometheus Laboratories

370. ProSciento

371. Protagonist Therapeutics

372. Protalix Biotherapeutics

373. Proven Process Medical Devices

374. Provenance Biopharmaceuticals

375. Pulmonary Hypertension Association

376. Qu Biologics

377. Qualcomm

378. Quest PharmaTech

379. Quintessence Biosciences

380. Ratio Drug Delivery

381. RAUMEDIC

382. Recipharm

383. Recro Pharma

384. Regeneron Pharmaceuticals

385. REM Systems

386. REMD Biotherapeutics

387. RemeGen

388. Resolve Therapeutics

389. rEVO Biologics

390. Rhythm Pharmaceuticals

391. Roehr pharmaceuticals

392. ROXALL Medizin

393. R-Pharm

394. Rubin Medical

395. RxActuator

396. Safe Save Medical Cell Sciences & Technology

397. Sagentia

398. Samsung Bioepis

399. Sandoz

400. Sanofi

401. Santarus

402. Saol Therapeutics

403. Savient Pharmaceuticals

404. scPharmaceuticals

405. Seattle Genetics

406. Selecta Biosciences

407. Selexys Pharmaceuticals

408. Senseonics

409. Sensile Medical

410. Serina Therapeutics

411. SFC Fluidics

412. Shanghai JMT-Bio

413. Shenzhen Salubris Pharmaceuticals

414. Shionogi

415. Shire

416. SHL Medical

417. Singularity University

418. Sinocelltech

419. SK Chemicals

420. SMC Global

421. Smiths Medical

422. Sonceboz

423. SOOIL Development

424. Sorrel Medical

425. SOTIO

426. SPARK Strategic Ideas

427. SQ Innovation

428. SteadyMed Therapeutics

429. Stealth BioTherapeutics

430. Stemline Therapeutics

431. Stevanato Group

432. Subcuject

433. Sumitomo Dainippon Pharma

434. Sun Pharmaceutical Industries

435. Sunovion Pharmaceuticals

436. Swissfillon

437. SymBio Pharmaceuticals

438. Symphogen

439. Synermore Biologics

440. Syntimmune

441. Syros Pharmaceuticals

442. TaiMed Biologics

443. Taiwan Liposome Company

444. Takeda Pharmaceutical

445. Tandem Diabetes Care

446. Tanvex BioPharma

447. Tarveda Therapeutics

448. Teva Pharmaceutical

449. TG Therapeutics

450. Theras Group

451. Theras Lifetech

452. Tianjin SinoBiotech

453. Tidepool

454. Tolero Pharmaceuticals

455. TRACON Pharmaceuticals

456. Transgene

457. Translational Sciences

458. TREOS Bio

459. Turnstone Biologics

460. Tyndall National Institute

461. TypeZero Technologies

462. Uni-Bio Science Group

463. Union Chimique Belge (UCB)

464. United BioPharma

465. United Therapeutics

466. University of Hertfordshire

467. University of Arizona

468. University of Bern

469. University of California

470. University of Colorado

471. University of Hertfordshire

472. University of Texas MD Anderson Cancer Center

473. University of Virginia

474. University of Virginia Patent Foundation

475. Vaccinex

476. Vaccinogen

477. Valtronic

478. vasopharm BIOTECH

479. VectivBio

480. Verily Life Sciences

481. Vetter Pharma

482. ViaCyte

483. ViCentra

484. Viela Bio

485. ViiV Healthcare

486. Vir Biotechnology

487. ViroMed Laboratories

488. Visterra

489. Vitareis

490. Vivozon

491. Weibel CDS

492. West Pharmaceutical Services

493. Wockhardt

494. Xbiotech

495. XEME Biopharma

496. Xencor

497. XOMA

498. Ypsomed

499. Zafgen

500. Zealand Pharma

501. Zensun

502. Zollner

503. Zuellig Pharma

Please note that the publisher limits purchases by consulting clients to either Consulting Company Team License or Global Site License for Entire Company. Any other selections will not be fulfilled by this publisher.